Combined chemotherapy and radiotherapy for advanced maxillary ameloblastoma. A case report.
A case of advanced maxillary ameloblastoma was successfully treated with combined intra-arterial chemotherapy (Peplomycin, 85 mg) and radiotherapy (Co60, 7080 r). The tumour showed a remarkable shrinkage, and the patient survived. He is still alive and well at the time of this report. Carefully applied chemotherapy combined with radiotherapy has a useful role in the management of ameloblastoma especially in an advanced maxillary tumour. This report presents a typical example, which indicates that the ameloblastoma may not be an inherently radioresistant and chemoresistant tumour.
Ueda
M
M
Dept. of Oral Surgery, Nagoya University, School of Medicine, Japan.
Kaneda
T
T
D000564:Ameloblastoma / Q000188:drug therapy* / Q000532:radiotherapy*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008441:Maxillary Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000532:radiotherapy*; D017663:Peplomycin
D000903:Antibiotics, Antineoplastic; D003037:Cobalt Radioisotopes; D001761:Bleomycin; D017663:Peplomycin